Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6525
    +0.0025 (+0.38%)
     
  • OIL

    83.05
    +0.24 (+0.29%)
     
  • GOLD

    2,337.80
    -0.60 (-0.03%)
     
  • Bitcoin AUD

    98,112.70
    -4,264.54 (-4.17%)
     
  • CMC Crypto 200

    1,332.43
    -50.14 (-3.63%)
     
  • AUD/EUR

    0.6082
    +0.0012 (+0.19%)
     
  • AUD/NZD

    1.0946
    +0.0005 (+0.04%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,076.77
    +36.39 (+0.45%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,016.23
    -72.47 (-0.40%)
     
  • Hang Seng

    17,268.17
    +66.90 (+0.39%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

3 Reasons Why Biohaven Pharmaceuticals' Stock Is Taking Off

3 Reasons Why Biohaven Pharmaceuticals' Stock Is Taking Off

A hot new migraine drug, positive financials, and several promising drug candidates in late-stage trials are luring investors to this stock.